5 completed, 3 terminated. 3 Phase 1, 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 3 | Terminated 3 |
Follow Pharmasset: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care PSI-7977, Daclatasvir, Ribavirin - Chronic Hepatitis C | Phase 2 | Completed | Bristol-Myers Squibb | 350 | 2011-06-01 | 2015-10-23 |
| ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN ASSOCIATION TENOFOVIR, TENOFOVIR + CLEVUDINE PLACEBO - HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection | Phase 3 | Terminated | French National Agency for Research on AIDS and Viral Hepatitis | 150 | 2008-12-14 | 2026-04-06 |
| Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus Clevudine, Adefovir - Chronic Hepatitis, Hepatitis B | Phase 3 | Terminated | Pharmasset | 2007-08-01 | 2009-04-27 | |
| Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus Clevudine, Adefovir - Chronic Hepatitis, Hepatitis B | Phase 3 | Terminated | Pharmasset | 2007-08-01 | 2009-04-27 | |
| Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin RO5024048 - Healthy Volunteers, Hepatitis C Virus | Phase 1 / Phase 2 | Completed | Pharmasset | 75 | 2006-10-01 | 2009-04-27 |
| Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects Racivir, a non-nucleoside reverse transcriptase inhibitor - HIV Infections | Phase 2 | Completed | Pharmasset | 60 | 2004-09-01 | 2007-07-03 |
| A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males Racivir - HIV Infections | Phase 1 | Completed | Pharmasset | 18 | 2002-06-01 | 2005-07-21 |
| A Study of DPC 817 in HIV-Infected Males DPC 817 - HIV Infections | Phase 1 | Completed | Pharmasset | 30 | 2005-07-19 |
HIV Infections (3) · Hepatitis B (3) · Hepatitis, Chronic (2) · Hepatitis (1) · Hepatitis C (1) · Hepatitis C, Chronic (1)
clevudine (3) · Racivir (2) · adefovir (2) · Ribavirin (1) · Sofosbuvir (1) · Tenofovir (1) · daclatasvir (1) · dexelvucitabine (1)
United States (6) · Puerto Rico (4) · Argentina (3) · Australia (2) · Canada (2) · China (2) · Greece (2) · Spain (2) · Taiwan (2) · Thailand (2) · United Kingdom (2) · Brazil (1) · France (1) · Germany (1) · Mexico (1)
M Michelle Berrey, MD, MPH (1) · M. Michelle Berrey, MD (1) · M. Michelle Berrey, MD, MPH (1) · Robert Murphy, MD (1)
2008 (1)